Literature DB >> 26976848

Interventions to improve medication adherence in coronary disease patients: A systematic review and meta-analysis of randomised controlled trials.

Karla Santo1, Suzanne Kirkendall2, Tracey-Lea Laba3, Jay Thakkar4, Ruth Webster3, John Chalmers3, Clara K Chow4, Julie Redfern3.   

Abstract

BACKGROUND: Adherence to multiple cardiovascular (CV) medications is a cornerstone of coronary heart disease (CHD) management and prevention, but it is sub-optimal worldwide. This review aimed to examine whether interventions improve adherence to multiple CV medications in a CHD population.
DESIGN: This study was based on a systematic review and meta-analysis according to Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines.
METHODS: Randomised controlled trials were identified by searching multiple databases and reference lists. Studies were selected if they evaluated interventions aiming to improve adherence to multiple CV medications targeting a CHD population and if they provided an appropriate measure of adherence. Interventions were classified as complex or simple interventions. Odds ratios (ORs) were calculated and pooled for a meta-analysis. Risk of bias, heterogeneity and publication bias were also assessed.
RESULTS: Sixteen studies (10,706 patients) were included. The mean age was 62 years (standard deviation (SD) 3.6) and 72% were male. In a pooled analysis, the interventions significantly improved medication adherence (OR 1.52; 95% confidence interval (CI) 1.25-1.86; p < 0.001) and there were no significant differences based on intervention type (complex vs simple), components categories and adherence method. There was moderate heterogeneity (I(2) ( )= 61%) across the studies. After adjusting for publication bias, the effect size was attenuated but remained significant (OR 1.35; 95% CI 1.09-1.68).
CONCLUSION: Interventions to improve adherence to multiple CV medication in a CHD population significantly improved the odds of being adherent. Simple one-component interventions might be a promising way to improve medication adherence in a CHD population, as they would be easier to replicate in different settings and on a large scale. © The European Society of Cardiology 2016.

Entities:  

Keywords:  Medication adherence; coronary disease; medication compliance; meta-analysis; multiple medications; polypharmacy; randomised controlled trial; systematic review

Mesh:

Substances:

Year:  2016        PMID: 26976848     DOI: 10.1177/2047487316638501

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  14 in total

Review 1.  Improving Medication Adherence in Coronary Heart Disease.

Authors:  Leah L Zullig; Katherine Ramos; Hayden B Bosworth
Journal:  Curr Cardiol Rep       Date:  2017-09-22       Impact factor: 2.931

2.  A systematic overview of systematic reviews evaluating medication adherence interventions.

Authors:  Laura J Anderson; Teryl K Nuckols; Courtney Coles; Michael M Le; Jeff L Schnipper; Rita Shane; Cynthia Jackevicius; Joshua Lee; Joshua M Pevnick
Journal:  Am J Health Syst Pharm       Date:  2020-01-08       Impact factor: 2.637

3.  Pharmacist Intervention to Improve Medication Adherence in Patients with Acute Coronary Syndrome: The PRIMA-ACS Study.

Authors:  Heather L Neville; Kelsey Mann; Jessica Killen; Michael Callaghan
Journal:  Can J Hosp Pharm       Date:  2021

4.  Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Protocol for a Randomized Controlled Trial Investigating Effects on Clinical Outcomes, Adherence, and Quality of Life.

Authors:  Malin Johansson Östbring; Tommy Eriksson; Göran Petersson; Lina Hellström
Journal:  JMIR Res Protoc       Date:  2018-02-20

5.  Pharmacist-Led Intervention to Enhance Medication Adherence in Patients With Acute Coronary Syndrome in Vietnam: A Randomized Controlled Trial.

Authors:  Thang Nguyen; Thao H Nguyen; Phu T Nguyen; Ha T Tran; Ngoc V Nguyen; Hoa Q Nguyen; Ban N Ha; Tam T Pham; Katja Taxis
Journal:  Front Pharmacol       Date:  2018-06-21       Impact factor: 5.810

6.  The effect of text message reminders on medication adherence among patients with coronary heart disease: A systematic review and meta-analysis.

Authors:  Ya-Yun Zhao; Fang-Ping Dang; Tian-Tian Zhai; Hui-Ju Li; Rui-Juan Wang; Jing-Jie Ren
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

7.  Evaluation of the efficacy and safety of text messages targeting adherence to cardiovascular medications in secondary prevention: the txt2heart Colombia randomised controlled trial protocol.

Authors:  Anderson Bermon; Ana Fernanda Uribe-Rodríguez; Paula Fernanda Pérez-Rivero; David Prieto-Merino; Diana Isabel Cáceres Rivera; Elizabeth Guio; Louise Atkins; Robert Horne; Elizabeth Murray; Norma Cecilia Serrano Díaz; Caroline Free; Pablo Perel; Juan P Casas
Journal:  BMJ Open       Date:  2019-12-08       Impact factor: 2.692

Review 8.  Healthcare provider-led interventions to support medication adherence following ACS: a meta-analysis.

Authors:  Jacob Crawshaw; Vivian Auyeung; Lucy Ashworth; Sam Norton; John Weinman
Journal:  Open Heart       Date:  2017-12-22

9.  TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.

Authors:  Clara K Chow; Aravinda Thiagalingam; Karla Santo; Cindy Kok; Jay Thakkar; Sandrine Stepien; Laurent Billot; Stephen Jan; Rohina Joshi; Graham S Hillis; David Brieger; Derek P Chew; Karin Rådholm; John J Atherton; Ravinay Bhindi; Nicholas Collins; Steven Coverdale; Christian Hamilton-Craig; Nadarajah Kangaharan; Andrew Maiorana; Michelle McGrady; Pratap Shetty; Peter Thompson; Anthony Rogers; Julie Redfern
Journal:  BMJ Open       Date:  2018-01-27       Impact factor: 2.692

10.  MEDication reminder APPs to improve medication adherence in Coronary Heart Disease (MedApp-CHD) Study: a randomised controlled trial protocol.

Authors:  Karla Santo; Clara K Chow; Aravinda Thiagalingam; Kris Rogers; John Chalmers; Julie Redfern
Journal:  BMJ Open       Date:  2017-10-08       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.